|
| 'Chitosan (1) | 1 (2) | 1, 3, 4 - oxadiazoles (1) |
| 1,2,3,4-tetrahydro-9Hpyrido [3,4-b] indole-3-carboxylic acid (1) | 1,3,4-Oxadiazole (1) | 1,3,4-Oxadiazoles (1) |
| 1-butyl-3-methyl imidazolium bromide (1) | 1-butyl-3-methyl imidazolium chloride. (1) | 1-methyl-4-phenyl-1 (1) |
| 12-Dimethylbenz[a]anthracene (1) | 18 β-glycyrrhetic acid (1) | 2 (2) |
| 2, 5-diaza bicyclo [4.3.1] compounds (1) | 2,2-diphenyl-1-picrylhdrazyl (1) | 2-(N-hydroxymethyl amino)-indol-3-yl-propanoic acid (1) |
| 2-aminobenzothiazole (1) | 2-Hydroxypropyl-β-cyclodextrin (1) | 23 factorial design (1) |
| 25(OH)2D (1) | 3 (2) | 3-Methyl-2-benzothiazonium hydrazone hydrochloride (1) |
| 32 factorial design (1) | 3D QSAR (1) | 3D-QSAR (1) |
| 3’ UTR region (1) | 4 - acetamido phenoxy acetyl hydrazide (1) | 4-dihydroxy-4-methoxybenzophenone- 2-O-β-d-glucopyranoside (1) |
| 4-pyridinecarboxylic acid hydrazide (1) | 4-Thiadiazole-2-amine (1) | 5-fluoroindolin-2-one (1) |
| 5-Fluorouracil (1) | 5-HT 3 receptor antagonists (1) | 5-Piperazinedione (1) |
| 6 (1) | 6-Mercaptopurine (1) | 6-Methylmercaptopurine (1) |
| 6-tetrahydropyridine (MPTP) (1) | 7 (1) | 7-Hydroxy warfarin. (1) |
| 8-iso-Prostaglandin F2α (1) | 99mTc-ciprofloxacin (1) | A. nilotica (1) |
| ABC analysis (4) | ABC-VED matrix (4) | Abdominal Pregnancy (1) |
| Abheshaja (1) | Absorbance ratio (1) | Absorption ratio (1) |
| ABTS (1) | Abuse (1) | Academic Stressors scale (1) |
| Accuracy. (1) | Accurate (1) | ACE (2) |
| ACE inhibitor (1) | Aceclofenac (1) | Acetazolamide (1) |
| Acetic acid induced rat colitis (1) | acetic acid induced writhing test (1) | Acetyl cholinesterase estimation (1) |
| Acetyl isoniazid (1) | Acetylation rate (1) | Acetylcholinesterase (1) |
| Acetylcholinesterase inhibitors (1) | ACF (1) | Acid hydrolysis (1) |
| Acid violet 43 (1) | Acid-resistant capsules (1) | Acne (1) |
| Acne vulgaris (1) | Aconitine (1) | Acquired immune deÞ ciency syndrome (1) |
| Acrylamide grafted ghatti gum; Biodegradable; Diclofenac sodium; pH-sensitive hydrogel; Controlled-release. (1) | Actinomycetes (1) | Activator procaspase-3 (1) |
| active pharmaceutical ingredient (1) | Active site (1) | Activities of daily living (ADL) scale (1) |
| Acupuncture (1) | Acute appendicitis (1) | Acute generalized exanthematous pustulosis (1) |
| Acute Inflammation (1) | Acute inß ammation (1) | Acute poisoning (1) |
| Acute ST segment elevation myocardial infarction (1) | Acute toxicity (1) | acyclovir (2) |
| Adenanthera (1) | Adenosine A 2A antagonist (1) | Adherence (5) |
| Adherence. (1) | Adiantum venustum (1) | ADME properties. (1) |
| ADR (2) | ADR management (1) | ADR monitoring centre (AMC). (1) |
| ADRs (2) | Adsorbent (1) | Adverse drug event (1) |
| adverse drug events (1) | Adverse drug reaction (9) | Adverse Drug Reaction (ADR) (1) |
| Adverse Drug Reaction and Antihypertensive medications. (1) | Adverse drug reaction. (1) | Adverse Drug Reactions (8) |
| Adverse drug reactions (ADRs) (1) | Adverse event following immunization (AEFI) (1) | Adverse events (1) |
| Adverse reaction (1) | Aedes aegypti (2) | Aerobic exercise (1) |
| Aerosil (1) | affective ; assessment ; cognitive ; learning domains ; psychomotor (1) | Age (2) |
| Ageratum conyzoides L (1) | air pollution (1) | Airjet (1) |
| Albendazole (1) | Albino mice (1) | Albino wistar rats (1) |
| Alcohol (2) | alcoholic extract (1) | ALDEN (1) |
| Aldose reductase inhibitors (1) | allantoin (1) | Allergic rhinitis (1) |
| Allergy (4) | Alloxan (1) | Alloxan monohydrate (1) |
| Alocasia indica Schott (1) | Aloe vera (1) | Alpha mangostin (1) |
| Alpha-adrenoceptor (1) | alpha-delta-bungarotoxin-4 (1) | Alpinia speciosa (1) |
| Alprazolam (1) | Alteration of drug cost (1) | Altered Mental Status (AMS) (1) |
| alternative therapy (1) | Alzheimer's disease (1) | Alzheimers disease (1) |
| Alzheimer’s disease (1) | Amaranthus spinosus Linn (1) | Amber (1) |
| Ambroxol hydrochloride (1) | Amides (1) | Amikacin Sulfate (1) |
| Amino acids (1) | amino benzylated Mannich bases (1) | amivudine (1) |
| Amlodipine (2) | Amlodipine besylate (2) | Ammonium salts (1) |
| Amoora cucullata. (1) | amoxicillin (1) | Amoxicillin sodium (1) |
| Anabolic. (1) | Anaemia (1) | Analgesia (1) |
| analgesic (8) | Analgesic effect (1) | analgesic- anti-inß ammatory activity (1) |
| Analgesics (1) | Analysis in capsules (1) | Analysis of variance (1) |
| Anaphylactic shock (1) | Anaphylaxis. (1) | and TGF–β (1) |
| Andragogy (1) | Anemia (1) | Anethum graveolens (1) |
| Angiogenic growth factors (1) | Angiotensin Converting Enzyme Inhibitors (1) | Animal model (1) |
| antepartum (1) | anthelmintic (1) | anthelmintic property (1) |
| Anthocyanin (1) | Anthracyclines (1) | Anti aging (1) |
| Anti hyperglycemic (1) | Anti inflammatory (1) | anti-anxiety activity (1) |
| Anti-asthmatic activity (1) | Anti-Cancer Activity (1) | Anti-diabetes mellitus. (1) |
| Anti-diabetic drugs (1) | Anti-epileptic drugs utilization (1) | Anti-HIV (1) |
| anti-hypertensive agent (1) | Anti-infective (2) | Anti-infective agents (1) |
| anti-inflammation (1) | anti-inflammatory (7) | Anti-inflammatory Activities of Total Leaf Extracts of Ficus sycomorus L. (Moraceae) used in Traditional Medicine in the Treatment of Sickle Cell Disease (1) |
| anti-inflammatory activity (2) | anti-inflammatory activity', (1) | anti-inflammatory agent (1) |
| anti-inß ammatory (3) | Anti-inß ammatory activity (1) | Anti-obesity (1) |
| Anti-oxidant (2) | Anti-parkinsonism activity (1) | anti-spasmodic drug (1) |
| Anti-tumor agent (1) | antiamnesic agents (1) | Antianxiety (1) |
| antibacterial (3) | antibacterial activity (4) | Antibacterial drugs (1) |
| Antibiotic (2) | antibiotic guidelines (1) | Antibiotic Resistance (2) |
| Antibiotics. (1) | Anticancer (4) | Anticancer activity (1) |
| Anticancer drugs (1) | Anticholinergic (1) | Anticoagulant (1) |
| Anticoagulant service (1) | anticonvulsant activity (1) | anticonvulsants (1) |
| Anticovulsant (1) | Antidepressants (1) | Antidesma bunius (2) |
| Antidiabetic (2) | Antidiabetic activity (2) | Antidiabetic agents (1) |
| antiepileptic agents (1) | Antiepileptic Drugs (2) | antifungal (1) |
| antifungal activity (1) | Antigen (1) | antigen protein (1) |
| Antiglycation (1) | Antihistaminic (2) | Antihyperglycemic (1) |
| Antihypertensive (1) | Antihypertensives (1) | Antiinflamatory (1) |
| Antimalarial (2) | Antimicrobial (4) | Antimicrobial activities (1) |
| Antimicrobial activity (6) | Antimicrobial agent (1) | Antimicrobial efficacy (1) |
| Antimicrobial resistance (1) | Antimicrobial resistance; Prescribing practice; Anti-infective agents; Antibacterials; Pharmacoepidemiology. (1) | Antimicrobial Stewardship (1) |
| Antimicrobials (4) | Antimosquito (1) | Antimycotic Activity (1) |
| antinociceptive (1) | Antioxidant (19) | Antioxidant ; carotenoid ; humans ; half-life ; status ; absorption . (1) |
| Antioxidant activity (6) | antioxidant effect (1) | Antioxidant properties (1) |
| Antioxidants (6) | Antipsychotics (1) | antipyretic (2) |
| Antiretroviral drugs (1) | Antiretroviral therapy (2) | Antispasmodic (1) |
| Antithrombotic (2) | Antithyroid drugs (1) | Antitubercular (1) |
| Antitubercular drugs. (1) | antiulcer (1) | Antivenom (1) |
| Antivenom reactions (1) | Antiviral (1) | antiviral activity (1) |
| Antiviral RNA (1) | Anxiety (2) | APAP (1) |
| APC (1) | Apoptosis (2) | Application (1) |
| Application to PK profile studies (1) | applications (1) | Appropriateness (1) |
| Aqueous extract (3) | AR Caps (1) | Arabic gum (1) |
| ARDS (1) | Area above the blood glucose levels-time curve. (1) | area of wound healing (1) |
| Areca nut (1) | Arginase (2) | Arginine (1) |
| Armodafinil (1) | ART (1) | Artemia salina (1) |
| Artemia salina. (1) | Artemisia absinthium (1) | Artemisia macrocephala (1) |
| arterial hypertension (1) | Arteriovenous malformation (AVM) (1) | Arthritis (1) |
| ARV Drugs (1) | Ascorbic acid (3) | Asenapine (1) |
| asian developing nations (1) | Asiaticoside (1) | Asparagus racemosus root extract (1) |
| Aspergillus niger (2) | Aspergillus niger. (1) | Aspergillus terreus (1) |
| Aspirin (1) | Assay (2) | Asthma (4) |
| Asymptomatic neurocognitive impairment (1) | Ataxia (2) | ATC/DDD (3) |
| Atenolol (1) | Atherosclerosis (2) | Atherosclerotic Vascular Disease (1) |
| Atorvastatin (5) | Atorvastatin calcium (1) | Atorvastatin. (1) |
| ATP synthase inhibitor (1) | ATP- sensitive K+channel (1) | Atractylis flava Desf (1) |
| Atrial fibrillation (1) | Atropine (1) | Attitude (6) |
| Attitude and practice (1) | Attitude. (1) | Aucubin (1) |
| Authors (1) | Authorship issues (1) | Autism spectrum disorders (1) |
| Auto antibody (1) | Auto medication (1) | Autoimmune disorders (1) |
| Autoimmunity (1) | Averrhoa bilimbi (1) | Avicel (1) |
| Awareness (2) | Ayurveda (1) | Azelaic acid (1) |
| Azilsartan medoxomil (1) | B cell epitope (1) | Bacoside A3 (1) |
| Bacterial isolates (1) | Bacteriological culture (1) | Bacteriostatic (1) |
| Bamboo betung (1) | Banana (1) | Bangladesh (2) |
| bark (1) | Barleria cristata (1) | Barriers (1) |
| Bauhinia racemosa (1) | Bauhinia variegata (2) | Bay-K-8644 (1) |
| Bayesian confidence propagation neural network (1) | BCG vaccine (1) | BCS-IV drug (1) |
| Beauty Salon Owner (1) | Beck Depression Inventory (1) | Beck Depression Inventory(BDI) (1) |
| Bedaquiline (1) | Belief (1) | Benchmarking (1) |
| Benzimidazole derivative (1) | benzimidazoles (2) | Benzodiazepines (1) |
| Benzothiazole analogues (1) | Berberis integerrima Bunge (1) | Beta-lactamic (1) |
| Bibliometrics (3) | Bioactive Metabolites (1) | Bioadhesive (1) |
| Bioanalytical method (1) | Bioanalytical method development (1) | Bioassay (1) |
| bioavailability (5) | Biodegradable (1) | Bioethics (1) |
| Biohazard (1) | Biologics (1) | Biology (1) |
| Biomedical (1) | Bioprospecting. (1) | Biopsy Proven Acute Rejection (1) |
| Biosafety (1) | Biosafety Engineering Control (1) | Biotechnology (1) |
| Bitter (1) | Black tea extract (1) | Bleaching (1) |
| Bleeding time (1) | Bleomycin (1) | Blonanserin (1) |
| Blood brain barrier (1) | Blood glucose (1) | Blood pressure (3) |
| Body Mass Index (1) | Boerhaavia Diffusa (1) | Bone (1) |
| Book Review (1) | Borg scale (1) | botulinum toxin (1) |
| Box-Behnken (1) | Brahmi vati (1) | Brain (1) |
| brand name drugs (1) | Branded medication (1) | Bratton-Marshall reagent (1) |
| Brazil (1) | Breast cancer (5) | Brewer’s yeast (1) |
| Brief COPE scale (1) | Brief medication questionnaire (1) | Brimonidine tartrate (1) |
| brine shrimp lethality bioassay (1) | Brine-shrimp lethality. (1) | Bromelain (1) |
| Bromeliaceae (1) | Bromocresol purple (1) | Bronchial Asthma (1) |
| Bryonia laciniosa (1) | Buccal (1) | Buccal Patches (1) |
| budget forecasting (1) | Bufadienolide (1) | Bullous eruption (1) |
| bungarotoxin (1) | Bungarus caeruleus (1) | Bungur (1) |
| Buni-berry extract (2) | Buoyant microspheres (1) | Burden Of Disease (1) |
| Business method (1) | Business model (1) | Butea monosperma (1) |
| C934 (1) | Ca2+ channels (1) | Cadmium chloride (1) |
| Caesalpinia decapetala (1) | Caesalpinia pulcherrima (1) | Caesalpinia pulcherrima (L.) Sw. stem bark (1) |
| Calcineurin inhibitor (1) | Calcium (1) | Calcium channel blocking (1) |
| calcium channel blocking activity (1) | Calcium oxalate (1) | Calcium silicate (1) |
| Calendula officinalis (1) | calendula oil (1) | Camelia sinensis extract (1) |
| Camellia sinensis (1) | Camptothecin (1) | Cancer (4) |
| Cancer Chemotherapy (2) | Cancer treatment (1) | Candida (1) |
| Candida albicans (3) | Candida albicans. (1) | Capacity (1) |
| Capsule (1) | capsules (1) | carbamazepin (1) |
| Carbamazepine (2) | carbohydrazide (1) | Carbomyl Linkage (1) |
| carbon tetrachloride (1) | carbonyl compounds (1) | Carbopol 940 (1) |
| Carcinoma. (1) | cardiac arrhythmias (1) | Cardiac remodeling (1) |
| Cardiology (1) | Cardioprotection (1) | Cardioprotective (1) |
| Cardiotoxicity (2) | Cardiovascular disease (1) | Cardiovascular drugs (1) |
| Carnauba wax (1) | carrageenan (2) | Caryocar coriaceum (1) |
| Case report (1) | Casein (1) | Casein Phosphopeptide-amorphous calcium Phosphate (1) |
| Catalase (1) | catalepsy (2) | Cation-pi (1) |
| CationicGuargum (1) | Causality assessment (2) | Causality scales (1) |
| CCKNOW - Crohn’s and Colitis Knowledge assessment questionnaire (1) | CD150 (1) | CD244.2 (1) |
| CD48 (1) | Cefixime (1) | Cefotaxime (1) |
| ceftriaxone and co-amoxiclav (1) | Cefuroxime Axetil (1) | cell viability Glycyrrhiza glabra (1) |
| Cellulase (1) | Cellulite (1) | Cellulitis (1) |
| Cellulose (2) | Cemented (1) | Cementless (1) |
| CEN (1) | Centella asiatica (3) | Central composite design (4) |
| Central post-stroke pain (1) | Cephalexin (2) | Cerebrovascular Accident (1) |
| Cervical dentine hypersensitivity (1) | CFFF (1) | chalcone (1) |
| chalcones (1) | Characterization (4) | Chemical stability (1) |
| Chemiluminescence (1) | Chemomechanical removal (1) | Chemometrics (2) |
| Chemotaxis (1) | Chemotherapy (5) | Chewing gum (1) |
| Child Care (1) | Children (2) | Children Dentistry (1) |
| Chitin (1) | Chitosan (6) | Chitosan Acetate. (1) |
| chitosan microspheres (1) | Chitosan nanoparticle (1) | Chitosan-g-HPβCD (1) |
| Chlamydomonas reinhardtii (1) | Chloramphenicol (1) | Chlorhexidine (2) |
| Chlorohexidine (1) | cholesterol (1) | Cholesterol HDL (1) |
| Cholinesterase inhibitors (1) | Chromotropic acid reagent (1) | Chronic Obstructive Pulmonary Disease (COPD) and Elderly Patient. (1) |
| Chrysophyllum cainito L. leaves (1) | Cicer arietinum (1) | Cigarette smoke (1) |
| Cilostazol (1) | Cinnamaldehyde (1) | Cinnamic acid derivatives (1) |
| Cinnamomum cassia (1) | Ciprofloxacin (1) | Citronella (1) |
| Citrus hystrix (1) | Citrus limon (2) | CKD (1) |
| CKMB. (1) | Claims (1) | Clarithromycin (1) |
| Classification (1) | Clastogenicity (1) | Cleistanthin A (2) |
| cleistanthin B (2) | Cleistanthus Collinus (1) | Clinical attachment (1) |
| Clinical attachment level (1) | Clinical efficacy (1) | Clinical equivalence (1) |
| Clinical manifestation (1) | Clinical Pharmacist (1) | Clinical pharmacist care (1) |
| Clinical pharmacology (1) | Clinical research (1) | Clinical trial (1) |
| Clinical trials (1) | Clinicians (1) | clonidine (2) |
| Clopidogrel (1) | Closed melt (1) | Clove (1) |
| cloxacillin (1) | Cluster analysis (1) | CME (1) |
| Co-crystal (1) | Co-Morbidity (1) | Co-morbidity. Correspondence (1) |
| co-precipitation method (1) | Co-surfactant (1) | Cochlopermum tinctorium (1) |
| coding system (1) | Cognition (2) | Cogrinding (1) |
| Colloidal carriers (1) | Colloidal silicone dioxide (1) | Colon targeted delivery (1) |
| Colon targeted drug delivery. (1) | Colon targeting (1) | Colonic delivery (1) |
| colorimetric assay (1) | Combination tablet (1) | Combination Therapy (1) |
| Combinatorial effect (1) | Comet assay (1) | common cold (1) |
| common cold and cough (1) | Common warts (1) | Community Pharmacies (1) |
| Community pharmacist (1) | Community pharmacy (1) | Comorbidity (1) |
| comparative molecular similarity indices (1) | comparative molecular Þ eld analysis (1) | compensation (1) |
| Complementary and alternative medicine (2) | complementary and alternative medicines (1) | Complementary and alternative therapy (1) |
| complete epithelization (1) | Compliance (1) | compound 48/80 (2) |
| compritol 888 ATO (1) | Computer (1) | Computer literacy (1) |
| computer-aided instructions (1) | Computer-aided learning (1) | Computerized screening systems (1) |
| CoMSIA (1) | Constipation (1) | Consumer (1) |
| Consumer perception (1) | Content validation (1) | content validity (1) |
| continuing education (1) | Contract research (1) | Contract research organizations (1) |
| Controlled release (4) | convolution (1) | convulsions (1) |
| cooperative practice (1) | COPD (2) | Coprocessed excipient (1) |
| Cordia obliqua (1) | Corneal opacities (1) | Coronally advanced flap (1) |
| Correlation (2) | Corticosteroid (2) | Corticosteroids (1) |
| Cosmetic (2) | Cost avoidance (1) | Cost of illness (2) |
| Cost saving (1) | Cost-effectiveness analysis (1) | Cost. (1) |
| Costing Analysis. (1) | Cotton oil (1) | cotton pellet (1) |
| Cough (1) | Cough medicine (1) | cough. (1) |
| Counterfeit Pharmaceutical Products (1) | Cramer’s Matrix method (1) | CRC (1) |
| Cream (1) | creatinine (1) | Critical Care Unit (CCU) (1) |
| Critical Thinking (1) | cromolyn sodium (1) | Croscarmellose sodium (CCS) (1) |
| Crospovidone (1) | Crospovidone (CP) (1) | Cross carmellose sodium (1) |
| cross-linking agents (1) | Crossandra (1) | Croton zehntneri (2) |
| Crystallinity (2) | CTCAE (1) | CTEPH (1) |
| Cucumis metuliferus (1) | Cucumis sativus (1) | CUMIN. (1) |
| Cuminosides (1) | Curcuma longa (1) | Curcumin (3) |
| current indian scenario of drug interactions (1) | curriculum development (1) | Cutaneous Adverse Drug Reactions (CADRs) (1) |
| CXCR4 (1) | Cyclodextrin (1) | Cyclooxygenase (1) |
| cyclophosphamide (1) | Cymbopogon citratus (1) | Cynodon dactylon (2) |
| CYP genes ; South Indian population ; polymorphisms (1) | Cyst (1) | Cytochrome P 2C9 (1) |
| Cytotoxic (1) | Cytotoxic activity. (1) | Cytotoxic agents (1) |
| Cytotoxicity (3) | CZE (1) | D&C (1) |
| D-optimal design (1) | Daily Defined Dose (1) | Dapsone (1) |
| Data mining algorithms (1) | DDX3 (1) | Death Receptors (1) |
| Decision making (1) | Deep vein thrombosis (1) | deferasirox (1) |
| deferiprone (1) | Deficiency (1) | Degradation (1) |
| Degradation studies (1) | Dehydrozingerone (1) | Delignification (1) |
| Delirium (2) | democratic government (1) | Dengue high fever (1) |
| Dental caries (3) | Dental Caries. (1) | dental management (1) |
| Dental prosthesis. (1) | Dental Students (1) | dentistry. (1) |
| Deodorants (1) | Dependence (1) | Depigmentant (1) |
| Depok Primary Health Care (1) | Deprescribing (1) | Depression (3) |
| Dermatology life Quality Index (1) | Design of experiments. (1) | desirability function (1) |
| Desirability index. (1) | Desmodium gangeticum (1) | Detorsion (1) |
| Deuterium (1) | device safety (1) | dexamethasone (2) |
| Dexibuprofen (1) | Dextrin (1) | Diabetes (5) |
| diabetes and diabetic vascular complications (1) | Diabetes mellitus (11) | diabetes mellitus, (1) |
| Diabetes Type-II (1) | Diabetes, glucose (1) | diabetic dyslipidemia (1) |
| Diabetic nephropathy (1) | Diabetic retinopathy (1) | Diabetic Wound (1) |
| Diacerein (1) | DiaKure (1) | diclofenac (1) |
| Diclofenac SLN (1) | Diclofenac sodium (1) | Dicots (1) |
| Dicyclomine (1) | differential scanning calorimetry (1) | diffuse transmittance (1) |
| Dillenia indica (2) | Dilleniaceae (1) | Diltiazem Efficacy (1) |
| Diltiazem hydrochloride (2) | Dimethylpyrimidin-derivatives (1) | Dip coating (1) |
| Diplotropis ferruginea (1) | direct compression (3) | Direct to consumer advertising (1) |
| Directly observed treatment short-course (1) | Discharge against medical advice (DAMA) (1) | discharge orders (1) |
| DISCLE (1) | Discrepancies (1) | Discriminant analysis (1) |
| Disease (1) | disintegration (1) | disintegration time (1) |
| Disproportionality Analysis (1) | Dissolution (5) | dissolution enhancement (1) |
| Dissolution rate (1) | Diuretic (1) | Diuretic activity (2) |
| DMAIC (1) | DMH (1) | DNA damage (1) |
| DNA fragmentation (1) | docking (3) | docking. (1) |
| Doctor (1) | Documentation and records (1) | Donepezil hydrochloride (1) |
| Dopamine (1) | Dosage formulation (1) | Dosage regimen (1) |
| Dose-dependent (1) | DOTS plus (1) | Doxorubicin (2) |
| Doxorubicin; FRAP assay (1) | Doxycycline (1) | DPPH Assay (1) |
| DPPH scavenging (1) | DRcaps (1) | DREEM. (1) |
| Dried blood spot. (1) | Dried blood spot; pharmacokinetic; validation; hydrochlorothiazide (1) | droplet size (1) |
| Drug (2) | Drug delivery denture (1) | Drug detailing (1) |
| drug disposal (1) | Drug Hypersensitivity (1) | Drug induced nephrotoxicity (1) |
| Drug Information and Literature Evaluation (1) | drug interaction (2) | Drug interaction (DI) (1) |
| drug interaction management (1) | drug interactions (2) | Drug prescriptions (1) |
| Drug product (1) | Drug Related Problems (4) | Drug related side effects (1) |
| drug release (1) | Drug Resistance (1) | Drug risk ratio (1) |
| Drug safety (2) | Drug Safety. (1) | Drug therapy (1) |
| Drug utilization (3) | drug utilization study (1) | Drug utilization. (1) |
| drug-drug interactions (4) | Drug-related problem (2) | Drug-SLS tablets. (1) |
| Drugedrug interaction (1) | Drugs (2) | drug–drug gliclazide (1) |
| Drug–drug interaction (1) | Dry extract cinnamon (1) | DSPC (1) |
| Dual Therapy (1) | dual-target-directed drugs (1) | Dunaliella salina (1) |
| Dynamic (1) | Dyslipidemias (1) | Dysphagia (1) |
| e-prescribing (1) | E. coli (1) | E.crispa (1) |
| Early-Related Complications (1) | EC50 values (1) | Economic (1) |
| Economic burden (1) | Edaravone (1) | Eddy’s hot plate method. (1) |
| edema (1) | Editorial (24) | Education (2) |
| Educational excellence (1) | efavirenz (2) | Efficacy. (1) |
| EGCG (1) | Egfr (1) | egg albumin microspheres (1) |
| Elderly (1) | Elderly Patients (1) | Electrochemical (1) |
| electrolyte release (1) | electrolytes (1) | Electron beam radiation (1) |
| Electronic prescribing (1) | Electronic prescription (1) | Electroporation (1) |
| Elevated plus maze (1) | elevated plus maze model (1) | Elisa (1) |
| Emblica offi cinalis (1) | Emergency contraception (1) | Emodin (1) |
| Emotional (1) | Emulgel (1) | Emulsification and Solvent Evaporation (1) |
| emulsion solvent diffusion method (1) | emulsion solvent diffusion-evaporation technique (1) | Encholirium spectabile (1) |
| Endocrine disruptor (1) | Endophytes (1) | Endothelial cells (1) |
| endothelial Nitric Oxide Synthase (1) | Endothelial progenitor cells (1) | Endothelium (1) |
| Endothelium. (1) | Enicostemma littorale (1) | Entire plant (1) |
| Entrapment afficiency (1) | entrapment efficiency (2) | Envenoming (1) |
| Environmental Factors (1) | Enzymatic hydrolysis (1) | eosinophil (1) |
| Epigallocatechin Gallate (2) | Epigallocatechin gallate (EGCG) (1) | Epigenetics (1) |
| epilepsy (4) | Epithelial ovarian cancer (1) | erbal drugs (1) |
| erice declaration (1) | Erythema (1) | Erythrina indica (1) |
| Erythrina variegata (1) | erythropoietin (1) | Escherichia coli (1) |
| Escitalopram oxalate (1) | esomeprazole (1) | Essential hypertension (2) |
| Essential medicine (1) | essential medicines (1) | essential oil (4) |
| essential oil composition (1) | Essential principles (1) | Estimated Glomerular Filtration Rate (1) |
| Estrogen receptor alpha (1) | Ethanol (1) | Ethanol extract (1) |
| ethanolic extracts (1) | Ethiopia (2) | ethnicity (2) |
| Ethnomedicine (1) | Ethosomes (1) | Ethyl - 4- acetamido phenoxy acetate (1) |
| Ethyl acetate (1) | Ethyl acetate fraction (1) | ethyl cellulose (2) |
| ethylcellulose (3) | ethylene glycol (2) | Eucalyptus (1) |
| Eucalyptus hybrid (1) | Eucalyptus oil (2) | eudragit (1) |
| Eudragit RL 100 (1) | eudragit S100 (2) | Eudragit-L100 (1) |
| Eudragit® S100 (1) | Eugenol (1) | Euphorbia hirta leaves (1) |
| Eurycoma Longifolia Jack (1) | Ex vivo tissue entrapment (1) | ex-vivo performance (1) |
| Ex-vivo permeation (1) | Ex-vivo study (1) | Excision wound model (1) |
| experiences (1) | Experiential learning (1) | Experimental ischemic stroke (1) |
| Expired medicines (1) | Exports (1) | Expression profile (1) |
| Extract (1) | Extrapyramidal side-effects (1) | extrinsic stains (1) |
| extrusion (1) | Eye lens (1) | Ezetimibe (2) |
| Fabaceae (2) | factorial design (5) | Factors associated with medication non-adherence (1) |
| Falcipain-2 (1) | Family Planning Services (1) | Family satisfaction (1) |
| family therapy (1) | famotidine (2) | fast disintegrating tablet (1) |
| Fast Disintegrating Tablets. (1) | Fast dissolving film (1) | Fast dissolving films (1) |
| Fast dissolving tablets (1) | Fasting serum insulin level (1) | Fat (1) |
| Fatty acid profile (1) | FC reagent (1) | FDA AERS Database (1) |
| FDA Approval (1) | Fenugreek (1) | Ferritin (1) |
| Ferrous sulfate (1) | Fialuridine', (1) | Ficus bengalensis (1) |
| Ficus bengalensis (Moraceae) (1) | Ficus racemosa (1) | film (1) |
| film hydration (1) | First permanent molars (1) | Fixed drug eruption (1) |
| Flavonoid (3) | Flavonoid Compounds (1) | Flavonoid fraction (1) |
| flavonoids (2) | Flavoxate HCl (1) | FlK-1 (1) |
| Floating beads (1) | floating controlled drug-delivery system (1) | Floating drug delivery system (1) |
| floating lag time (1) | fluoroquinoes (1) | Fluoxetine (1) |
| Flupritine maleate (1) | flurbiprofen (1) | Flux (1) |
| folkloric use (1) | Food drug and cosmetic act (1) | Forced degradation (3) |
| Forced degradation studies (1) | forced swim test (1) | Formulary (1) |
| Formulary. (1) | Formulation (2) | Formulation and development (1) |
| Fourier transform infra red spectroscopic (1) | FPG (1) | FPGEE (1) |
| Fraction (1) | Franz Diffusion Cell (3) | free radical scavenger (1) |
| Free radicals. (1) | Freeze-drying (1) | Freund’s complete adjuvant (1) |
| Fructo-Oligosaccharide (FOS) (1) | Frusemide (1) | Frusemide-induced complications (1) |
| FTIR (4) | Fumes (1) | furosemide (1) |
| Galacto-Oligosaccharide (GOS) (1) | Galic Acid (1) | gallic acid (2) |
| Gamma irradiation (1) | Gangrenous (1) | Ganoderma lucidum (1) |
| Gap Junctions; Hypersynchronization; Pentylenetetrazole; Maximal Electroshock (1) | Garcinia daedalanthera extract (1) | Garcinia imberti bourd (1) |
| Garcinia indica (1) | Garcinia latissima (1) | gaseous contact (1) |
| gastric treatment (1) | Gastric ulcer (1) | Gastro-retentive drug delivery system (1) |
| gastroprotection (2) | gastroretentive (1) | gastroretentive drug delivery system (1) |
| Gatot Soebroto hospital. (1) | GC-MS (1) | GC-MS analysis (2) |
| GC-MS. (1) | Gelatin (1) | Gelling Capacity. (1) |
| Gels (1) | gemfibrozil (1) | Gender (1) |
| Gender and HIV. (1) | Gene expression (1) | Gene expressions (1) |
| Gene silencing (1) | General medicine (1) | Generic (2) |
| generic drugs (1) | Generic medicines (2) | Generic name. (1) |
| Generic substitution (1) | Generics (1) | Genetic polymorphisms (1) |
| genetic Signature (1) | Genotype frequency (1) | Gentamicin (4) |
| gentamicin sulfate (2) | Geriatrics (3) | GFAP (1) |
| Gibb’s reagent (1) | Ginger (1) | Gingival hyperplasia (1) |
| Gingival hypertrophy (1) | gingival pocket (1) | Gingival recession (1) |
| Gingival thickness (1) | Gladiolus segetum (1) | glibenclamide (4) |
| gliclazide (2) | Glimepiride (2) | glimepride (1) |
| Glipizide (3) | glitazars (1) | Global education (1) |
| Glomerulonephritis (1) | Glucagon (1) | Glucocorticoids (1) |
| Glucose (1) | glucose tolerance test (1) | glutathione (1) |
| Glycerine (1) | Glycine max (1) | Glycosylated hemoglobin (HbA1c) (1) |
| Glycosylated hemoglobin A1c (1) | Gnetum gnemon (2) | Goal orientation (1) |
| Goldenhar syndrome (1) | good manufacturing practices (1) | Gotu kola leaves extract (1) |
| GPx (1) | Graft Survival (1) | Grafting (1) |
| Gram negative (1) | Gram positive (1) | Grape seed extract (1) |
| Grape seed oil (1) | Grapes seed extract (1) | Gravimetry (1) |
| Grazing angle X-ray diffraction (1) | Green tea (1) | Green Tea Leaves Extract (2) |
| Griseofulvin (1) | GSH (2) | guanyl cyclase stimulator (1) |
| Guest Editorial (1) | Guidelines (1) | Gulf cooperation council (1) |
| Gum and fat fractions (1) | Gum arab (1) | Gymnema Sylvestre (2) |
| GYTS (1) | H+ (1) | H-460 (1) |
| H2 Receptor Antagonist (1) | H2O2 (1) | HAART (1) |
| Haematological (1) | Haemoglobin (1) | Haemolytic ratio. (1) |
| Hair dye. (1) | Hair Growth Activity (1) | Hair Tonic (1) |
| Hajj (1) | haloperidol (1) | Hand and Foot Syndrome (1) |
| hardness (1) | harmacotherapy-based problems (1) | Harmonization (2) |
| Hazardous drugs (1) | HbA1C (2) | HBV (1) |
| HCT: Hydrocholrothiazide. (1) | HDAC4 (1) | HDAC7 (1) |
| head twitch (1) | Health benefits (1) | Health care profession (1) |
| health care professionals (1) | health care students (1) | Health care. (1) |
| Health Hazard (1) | Health informatics (1) | Health Information Technology (1) |
| Health problems (1) | Health Services Accessibility (1) | Healthcare (4) |
| healthcare communication (1) | Healthcare Delivery (1) | healthcare expenditure (1) |
| Healthcare Professionals (1) | healthcare providers (1) | Healthy volunteers (1) |
| heart failure (2) | Hematological parameters (1) | hematological toxicity (1) |
| Hematology (2) | Hematoma (1) | Hematopoietic progenitors (1) |
| hepatic impairment (1) | Hepatitis (1) | Hepatitis B (1) |
| Hepatitis B virus core protein (1) | Hepatocellular (1) | Hepatocurative (1) |
| hepatoprotective (2) | hepatoprotective activity (3) | Hepatotoxicity (1) |
| HER1 (1) | HER2 (1) | HER3 (1) |
| HER4 (1) | Herbal active ingredients (1) | Herbal drugs (1) |
| Herbal medications (1) | Herbal medicine (2) | herbal medicines (1) |
| Herbal therapy (1) | Herbaldb (1) | HET-CAM (1) |
| Heterocyclic compound (1) | Heterotopic Pregnancy (1) | Hex (1) |
| Hexane (1) | Hibiscus cannabinus Linn. (1) | Hibiscus rosa. (1) |
| High fat diet (3) | High Fat Diet Model (1) | High impact resin (1) |
| high performance liquid chromatography (1) | high performance thin layer chromatography (1) | High-density lipoprotein cholesterol (1) |
| High-fat diet (1) | high-performance liquid chromatography (2) | High-throughput screening (1) |
| Higher education (1) | highly active antiretroviral therapy (1) | Highly Cited Papers (1) |
| Himatanthus drasticus (1) | Hip Arthroplasty (1) | Hirsutism (2) |
| Histocompatibility. (1) | Histological studies. (1) | Histopathological studies (1) |
| Histopathology (2) | HIV (1) | HIV associated dementia. (1) |
| HIV-1 RT (1) | HIV-associated neurocognitive disorder (1) | HIV/AIDS Patients (1) |
| HL-60 and K-562 (1) | HLA (1) | HMG-CoA Reductase (1) |
| homology modeling (1) | Honey (1) | Honeycomb (1) |
| Hordeum vulgare (1) | Hordeum vulgare hull (1) | Hospital pharmacy (2) |
| hospitalized children (1) | hospitalized patients (1) | Hospitals (1) |
| host (1) | Host-guest interactions (1) | hot plate (1) |
| HP-ß Cyclodextrin complexes (1) | HPLC (8) | HPLC (High Performance Liquid Chromatography) Ornidazole (1) |
| HPLC method validation (1) | HPLC. (1) | HPMC (1) |
| HPMC capsules (1) | HPMC K100M (1) | HPMC K4M (1) |
| HPTLC (5) | HRQoL (2) | HSV-1 (1) |
| Human breast cancer cells (1) | Human breast cancer MCF -7 cells (1) | human immunodeficiency virus (3) |
| human immunodeÞ ciency virus (1) | Human Papillomavirus (1) | Human plasma (2) |
| human plasma level (1) | Human plasma; Liquid chromatography–tandem mass spectrometry (LC–MS/MS); Method validation; Pharmacokinetics (1) | Humanitarian device exemption. (1) |
| Hydnocarpus Pentandra (1) | Hydralazine hydrochloride (1) | Hydroalcoholic (1) |
| hydrochlorothiazide (1) | Hydrochlorthiazide (1) | hydrogel (2) |
| Hydrogels (1) | hydrogen sulfide (1) | hydrogenated castor oil (1) |
| Hydrophilic drugs (1) | Hydrophillic sealants (1) | Hydrophobic sealants (1) |
| hydroxy propyl methyl cellulose (1) | Hydroxyl radical (1) | hydroxypropyl cellulose (1) |
| hydroxypropyl methyl cellulose (2) | Hydroxypropyl methylcellulose (1) | Hydroxypropyl methylcellulose E15 (1) |
| Hydroxypropyl-β- cyclodextrin (1) | Hydroxypropylmethyl cellulose (1) | Hydroxypropylmethylcellulose (1) |
| Hyperactive orofacial musculature (1) | Hypercholesterolemia (1) | Hypercholestremia (1) |
| Hyperglycemia (1) | Hyperglycemic (3) | Hyperglycemic mice (1) |
| Hyperhomocystienemia (1) | Hyperlipoprotienemia(a) (1) | hyperoxaluria (1) |
| Hypersensitivity (1) | hypertension (5) | Hypertension( HTN) (1) |
| Hypertensive’s (1) | Hyperthyroidism (1) | hypertriglyceridemia (2) |
| Hypertrophy (1) | Hyperzincuria (1) | Hyphenated system (1) |
| hypoglycemic (1) | Hypoglycemic activity (1) | hypolipidemic (1) |
| Hypothyroidism (1) | Hypozincaemia (1) | IBD (1) |
| IBD - Inflammatory Bowel Disease (1) | IC50 (2) | ICH (2) |
| ICH guidelines (2) | ICP22 (US1) gene (1) | IL-17 (1) |
| IL-6 (2) | IL-MAE (2) | Illiterate (1) |
| Iloperidone (1) | image analysis (1) | imidazole (1) |
| Immune response (1) | Immune suppression (1) | immunocytochemistry (1) |
| Immunoinformatics (1) | Immunological response (1) | Immunomodulatory (1) |
| Immunomodulatory effect (1) | In silico (2) | in situ gelation (1) |
| in vitro (4) | In vitro kinetics (1) | In vitro penetration lotion (1) |
| In vitro penetration test (1) | In vitro Penetration Test. (1) | In vitro release (1) |
| In vitro–In vivo (1) | in vivo (1) | In vivo kinetics (1) |
| In-patien (1) | in-vitro dissolution study (1) | In-vitro skin permeation (1) |
| Inclusion complex (1) | inclusion complexes (2) | indexed cost (1) |
| India (7) | India. (1) | Indian context (1) |
| Indian Traditional medicine (1) | Indion 234 (2) | Indion resin (1) |
| indomethacin (2) | Indonesia (1) | Indonesian Herbal Database. (1) |
| Indonesian National Health Insurance (1) | Industry (1) | Inequality (1) |
| infarct size (1) | infective endocarditis (1) | infertility (1) |
| inflammation (3) | inflammatory bowel disease (2) | Information need (1) |
| Information system (1) | Information Technology Officers (1) | Information tool (1) |
| Inhibitor MDM2 (1) | innovation ecosystems (1) | inorganic salts. (1) |
| INR (1) | inß ammation (2) | inß ammatory bowel diseases (1) |
| Insilico anticancer screening (1) | insulin (5) | Insulin receptor (1) |
| Insulin regimen (1) | insulin resistance (1) | Insulin resistance. (1) |
| insulin use in primary care (1) | Insulinophobia (1) | Integrase inhibitor (1) |
| Integrated Courses (1) | integrated economic analysis (1) | Intellectual Property l (1) |
| Intellectual property rights (1) | intelligent tutoring (1) | Intensive care unit (1) |
| Intensive Care Unit (ICU) (1) | Intensive Monitoring (1) | interaction (2) |
| interferon (1) | interleukins (1) | International Collaboration (1) |
| International HIV dementia scale (IHDS) (1) | international organization (1) | international organizations (1) |
| international trade (1) | Internet (1) | interpretation (1) |
| Interventional tool (1) | Intracanal medicament (1) | intraocular presuure (1) |
| Intrauterine Pregnancy (1) | inventory index (1) | inventory management (3) |
| investigators (1) | Invited Article (2) | ion pair complex (1) |
| Ionic gelation (1) | Ionic liquid (3) | Ionic liquid- based microwave-assisted extraction (1) |
| ionic liquid-based microwave-assisted extraction (1) | ionotropic gelation (1) | iontophoresis (2) |
| Iraq (1) | Iridoid glycoside (1) | iron chelation therapy (1) |
| Irvingia gabonensis (1) | isatin (3) | ischemia (1) |
| ischemia-reperfusion injury (1) | Ischemic (1) | ischemic heart disease (1) |
| ISO (1) | isoniazid (2) | isonicotinohydrazide (1) |
| Isoprinosine (1) | Isopropyl myristate (1) | isoproterenol (1) |
| isoxazoline (1) | itopride HCl (1) | JNC 8 Guidelines. (1) |
| Journal (1) | Jurkat (1) | K+-ATPase β subunit (1) |
| K+ATP channel (1) | K-CAPS (1) | K562 (1) |
| Kaffir lime (1) | Kajjali (1) | Kalanchoe Pinnata (1) |
| KAP (1) | KAP study (1) | Kappa. (1) |
| Karachi (2) | Kathakakhadiradi kashyam (1) | Kati chakrasana (1) |
| Kernel powder (1) | Ketoprofen (1) | Ketorolac (1) |
| Ketorolac salt (1) | Key words: 5-FU (1) | Key words: Esomeprazole (1) |
| kidney (2) | kinetic drug release (1) | Kinetic Modelling (1) |
| KMnO4 (1) | kneading method (1) | kneading technique (1) |
| knowledge (9) | Kumar’s score (1) | L-arginine (1) |
| L-Thyroxine (1) | L. acidophilus (1) | labeling (1) |
| Laboratory findings. (1) | Lactobacilli (2) | Lactobacillus (1) |
| Lag period (1) | Lagenaria siceraria (1) | Lantana camara (1) |
| Lantana montevidensis (1) | Larvacidal (1) | Laurence-Moon-Bardet-Biedl Syndrome (1) |
| Lawsone methyl ether (1) | LC/MS/MS (1) | LC50 (1) |
| LCMS/MS (1) | LC–MS/MS (1) | LDL-C (1) |
| Leaf (1) | Learning process (1) | leaves (4) |
| Leftover medicines, (1) | Leg Length (1) | Leptin (1) |
| Letter to Editor (4) | Letter to the Editor (3) | Letters to the Editor (6) |
| Leucaena leucocephala (1) | Leucas lavandulaefolia (1) | Levocetirizine (1) |
| Lichen planus (1) | Licofelone (1) | Ligand-based drug design (1) |
| Lightening (1) | Limb Length (1) | Limbs (1) |
| lime fruit (1) | Linoleic acid (1) | lipid matrix (1) |
| lipid metabolism (2) | lipid microspheres (1) | Lipid nanocrystals (1) |
| Lipid peroxidation (3) | lipid peroxides (1) | lipid profile (1) |
| Lipid profile membrane bound enzymes (1) | lipids (1) | lipoic acid (1) |
| liposome (1) | Lippia (1) | lithium toxicity (1) |
| Live-well™ (1) | liver function (2) | Liver necrosis (1) |
| Liver tonic (1) | Liver Transplantation (1) | Local drug delivery (1) |
| locomotor activity (1) | Low-density lipoprotein cholesterol (1) | Lozenges (1) |
| Luffa echinata (1) | Luminesce (1) | Lung (1) |
| Lung cancer (3) | Lupenoic acid (1) | Lupus (1) |
| Lycatab C (1) | Lympadenopathy (1) | lymphadenitis (1) |
| Lysozyme (1) | M. tuberculosis H37Rv (1) | Maceration (1) |
| Macromicroscopy study (1) | Macrophage cell line (1) | Mahkoside A (1) |
| Major Contributed Organizations (1) | Malaysia (4) | Malaysia. (1) |
| Malaysian. (1) | malondialdehyde (2) | Maltodextrin (2) |
| Mammary carcinoma (1) | Mandibular hypoplasia (1) | Mangiferin (1) |
| Mangosteen Peels (1) | manidipine dihydrochloride (1) | Mannich base (1) |
| Mannich Bases (1) | Marine fungi compounds (1) | Mast cell (1) |
| Maternal Care. (1) | matrix (1) | Matrix Tablet (1) |
| matrix tablets (3) | MCF-7 (1) | MDA (2) |
| MDR-TB (2) | mean age (1) | mechanisms (1) |
| Meclizine HCl (1) | Medical (1) | medical costs (1) |
| Medical device (1) | Medical device recalls (1) | medical errors (1) |
| Medical informatics (1) | Medical Inpatients (1) | Medical practitioner (1) |
| Medical Representative (1) | Medical sales representative (1) | Medical students (2) |
| medication adherence (4) | medication adherence behaviour (1) | medication error (2) |
| Medication errors (1) | Medication non-adherence (1) | Medication reconciliation (1) |
| Medication regimen complexity (1) | medication safety (1) | medication-/drug-related problem (MRP/DRP) (1) |
| Medicinal plants (2) | Medicine (2) | Medicine disposal (1) |
| medicine-use practices (1) | Medicines storage (1) | Medicines wastage (1) |
| Melanesia (1) | Melastoma malabathricum (1) | Melinjo (2) |
| Meloxicam (1) | Memory (1) | Memory and learning. (1) |
| Men (1) | Menstrual cycle (1) | Mental health (1) |
| Mental health services. (1) | Mentha arvensis (1) | mesalamine (1) |
| Metabolic ratio (1) | Metabolic syndrome (1) | Metabolism (1) |
| Metabolite profiling (1) | Metabomics (1) | metagenomic (1) |
| metformin (7) | metformin hydrochloride (1) | Methanol (1) |
| methanolic extract (1) | methocel (1) | method development (2) |
| method validation (3) | Methotrexate (1) | methyl orange (1) |
| methyl-b cyclodextrin (1) | metoprolol tartarate (1) | MetS (1) |
| Mevalonate (1) | Micro emulsion (2) | Micro particles. (1) |
| Micro-emulsion (1) | microbial contamination (1) | Microbiological (1) |
| Microbroth dilution (1) | Microcapsules (1) | microcrystalline cellulose (5) |
| microdilution (1) | Microdosing (1) | Microencapsules (1) |
| microneedles (1) | Micronucleus assay (1) | microparticles (1) |
| microsphere (1) | Microsphere Phytosome (1) | microspheres (6) |
| microtriches (1) | Microwave assisted extraction (1) | Microwave-Assisted Extraction (2) |
| miglitol (1) | Migraine (2) | migraine management, (1) |
| Mild neurocognitive disorder (1) | Milk (1) | Milnacipran (1) |
| Mimosa pudica (1) | Mineral trioxide aggregate (1) | minimal inhibitory dose (1) |
| Minimum Inhibitory Concentration (MIC) (1) | mismatches (1) | mitochondria (1) |
| Mix mode (1) | MMAS-8 - Modified Morisky Adherence Scale-8 (1) | Modeling (1) |
| modern medicine (1) | modified melt dispersion technique (1) | Modified Starches (1) |
| MODY (1) | Mol inspiration (1) | Molecular characterization (1) |
| Molecular docking (10) | molecular docking and anti cancer activity. (1) | Molecular Docking. (1) |
| Molecular Dynamic (1) | Molecular dynamics (3) | Molecular Dynamics Simulations (1) |
| Molecular Imprinted Polymer (1) | Molecular mimicry (1) | monoamine oxidase B (1) |
| Monocots (1) | montelukast (2) | montelukast sodium (1) |
| Montelukast, (1) | moraceae (1) | Morbidity (1) |
| Morin and validation (1) | Moringa oleifera (2) | Moringa oleifera. (1) |
| Morisky medication adherence questionnaire (1) | Mortality (3) | Morus alba (1) |
| Mosquito repellent (1) | Mouth Dissolving Tablets (1) | mouth-dissolving film, (1) |
| MPO activity (1) | MPTP (1) | MTT Assay (2) |
| MTT method (1) | MUC2 (1) | MUC6 (1) |
| Mucoadhesive (1) | Mucoadhesive agent (1) | mucoadhesive formulation (1) |
| Mucoadhesive Oral In situ gel (1) | mucoadhesives (1) | mucodhesive (1) |
| Mulberry (1) | multi granules (1) | multidrug resistant pathogens (1) |
| Multikinase Inhibitor (1) | multiparticulates (1) | multiparticulates dosage form (1) |
| Multiple myeloma (1) | multiple regression (1) | multiple regression analysis (1) |
| Multitargeted drug (1) | Murraya koenigii L.Sprengel S.mutans (1) | Mycobacterium tuberculosis. (1) |
| Mycophenolate mofetil (1) | Mycophenolic acid (1) | Myeloperoxidase (1) |
| myocardial infarction (1) | Myomectomy. (1) | Myrica esculenta (1) |
| Myristicin (1) | N-aminoimidazoles (1) | N-napthyl ethylene diamine dihydrochloride (1) |
| Na+/K+-Atpase (1) | NABP (1) | NACO. (1) |
| Nadi shuddhi pranayama (1) | Naftopidil (1) | nano size (1) |
| Nanoemulsion (1) | Nanoformulation (2) | nanoformulations (1) |
| Nanonization. (1) | Nanopacticle (1) | Nanoparticle (1) |
| Nanoparticles (9) | Nanosuspension (1) | Nanosuspension tablets (1) |
| Nanosuspensions (1) | Naphthoquinone derivative (1) | NAPLEX (1) |
| naproxen (1) | Naranjo (1) | Naranjo algorithm (2) |
| Naranjo algorithm. (1) | Naranjo’s ADR probability scale (1) | Narikel Lavan (1) |
| Narrow therapeutic index drugs (1) | Nasal gel (1) | Nateglinide (1) |
| National Fomulary (1) | National Formulary (2) | National Health and Morbidity Surveys (1) |
| National Public Health Programs (1) | Natural (1) | natural compounds (3) |
| Natural Polymers (1) | natural products (2) | NCC-PvPI; Hepatitis B vaccine; ADR/AE; VigiFlow; system organ class (SOC) (1) |
| Nebivolol (2) | nebivolol hydrochloride (1) | Necrosis. (1) |
| need assessment (1) | Nephroprotective (3) | Nephrotic syndrome (1) |
| Nephrotoxicity (1) | Nerium indicum (1) | neuropathy (1) |
| Neurosurgical (1) | neutropenia (1) | nevirapine (1) |
| new molecule (1) | Newborns (1) | Nicorandil (1) |
| Nicotine (1) | Nicotine dependence (1) | Nifedipine. (1) |
| Nigeria. (1) | nigrostriatal pathway (1) | Nil (8) |
| Nill (18) | niosome (1) | Niosomes (1) |
| Nitric acid (1) | Nitric oxide (3) | Nitrogen starvation (1) |
| NK cell (1) | NMDA (1) | NMDA receptors (1) |
| Nodular skin lesions (1) | Non-linear (1) | non-prescription medicine use (1) |
| Non-steroid anti-inflammatory (1) | Non-steroidal anti-inflammatory drugs (1) | Non-surgical endodontic therapy. (1) |
| nonamers. (1) | noncommunicable disease (1) | noncompliance (1) |
| Nonionic surfactants (1) | nootropic (1) | Norfloxacin (1) |
| Normoglycemic rats (1) | northeast India (1) | Nose to brain delivery (1) |
| Nothopanax scutellarium (1) | Nuclear medicine (1) | nuclear pharmacy (1) |
| Nucleo CMP (1) | Nude mice (1) | Nutmeg oil (1) |
| Nutraceuticals (1) | Nutrient starvation (1) | Nutrition (1) |
| Nystagmus Phenytoin toxicity (1) | O-Phenylene diamine (1) | Obesity (2) |
| Occupational health (1) | Ocimum gratissimum (1) | Off-label (1) |
| offending drugs (1) | Okra Mucilage (1) | Olmesartan (1) |
| olmesartan medoxomil (1) | Omega-6 fatty acid (1) | Omeprazole. (1) |
| Omics (1) | Oncology. (1) | ondansetron (3) |
| ondansetron hydrochloride (1) | OPD – Outpatient Department. (1) | open field (1) |
| Ophthalmic (1) | ophthalmic delivery (1) | ophthalmic inserts (1) |
| Opportunities (1) | Optimal stress (1) | optimization (7) |
| Oral bacteria (1) | Oral cancer (2) | oral disintegrating tablets (1) |
| Oral glucose tolerance (1) | oral glucose tolerance test (3) | Oral hypoglycemic drugs (1) |
| oral insulin (1) | Oral Rehabilitation (1) | Organ Toxicities (1) |
| organic acids (1) | organogel (1) | Organophosphate (1) |
| Origanum vulgare (1) | Original Article (3) | Originator. (1) |
| Orlistat (1) | orodispersible tablet (1) | orodispersible tablets (2) |
| Oscillopsia (1) | Osmotic pump (1) | Osteoarthritis (1) |
| Osteoblast (2) | Osteoclast (1) | OTC switch (1) |
| Otomycosis (2) | Outdoor patients (1) | Outpatients (1) |
| ovalbumin (1) | Ovarian (1) | Over-the-counter (1) |
| Overweight (1) | OVX (1) | oxazepinone (1) |
| oxcarbazepine (1) | Oxidation (1) | oxidative damage (1) |
| oxidative stress (6) | Oxyresveratrol (1) | oxytetracycline (1) |
| P-dimethylaminobenzaldeyde (1) | P-drug. (1) | P-drugs (1) |
| P-glycoprotein (1) | P. dulce (Fabaceae) (1) | p53 tumor suppressor gene (1) |
| Package insert (1) | Paediatric (2) | Pain (2) |
| Pain. (1) | Painkiller (1) | pair wise procedures (1) |
| Pakistan (2) | Pakistan. (4) | Paliperidone palmitate (1) |
| Pancreatitis. (1) | Pantoprazole (1) | papain (1) |
| Papain. (1) | PAR-2 receptor (1) | para-diaminobenzaldehyde (1) |
| paracetamol (2) | Paracetamol. (2) | Parkinson’s disease (1) |
| partial least square (1) | particle size analysis (1) | PASS (1) |
| passive avoidance learning (1) | Patch (1) | patents (2) |
| Pathological response (1) | Patient (2) | Patient adherence. (1) |
| patient counseling (1) | Patient counseling and Patient information leaflet (1) | patient education (1) |
| Patient health questionnaire (PHQ) (1) | Patient satisfaction (1) | Patient Survival (1) |
| patient-physician communication (1) | Patient-safety (1) | patients (2) |
| Patients. (1) | paw edema (1) | Paw edema. (1) |
| Paw volume (1) | PE 18:0/18:0-PEG 2000 (1) | Pectin (1) |
| pedagogy (1) | Pediatric (3) | Pediatric cancer (1) |
| Pediculosis (1) | Pegagan extract (1) | PEGylation (1) |
| Pemphigus vulgaris (1) | Penang (1) | penetration (3) |
| penetration enhancer (1) | penetration pressure (1) | penicillamine (1) |
| Penicillins (1) | pentylenetetrazole (1) | PEO (1) |
| Peperomia pellucida (L) Kunth (1) | Peperomia pellucida (L.) Kunth (3) | Peppas and Higuchi’s equations (1) |
| Peptic Ulcer. (1) | peptide vaccine (1) | Peptidoglycan (1) |
| percentage healing of wound area (1) | perception (3) | Periauricular tags. (1) |
| pericyclic fiber (1) | Periodontal disease (1) | periodontal diseases (1) |
| Periodontal dressing (1) | periodontal pocket (1) | Peripheral Neuropathy (1) |
| Permeation (2) | Peroxisome proliferator-activated receptorg (PPAR-γ) agonists (1) | Persistent ulcer (1) |
| Personal care products (2) | pH dependent approach (1) | pH independence (1) |
| pH-sensitive (1) | Phaleria marcocarpha (1) | Pharm. D. Integrated (1) |
| Pharm. D. Post Baccalaureate. (1) | pharma counseling (1) | pharmaceutical (1) |
| pharmaceutical advertisements (1) | Pharmaceutical care (2) | pharmaceutical care. (1) |
| pharmaceutical formulations (1) | Pharmaceutical Marketing (1) | Pharmaceutical Services (1) |
| Pharmaceutical-Care (1) | Pharmaceutical-industries (1) | Pharmacist (4) |
| Pharmacist intervention. (1) | pharmacist role in public health (1) | Pharmacists (1) |
| pharmacists India (1) | Pharmacodynamic (2) | Pharmacodynamic activity (1) |
| pharmacodynamics (2) | Pharmacogenetics (1) | Pharmacogenomics (1) |
| pharmacognostic standardization (1) | pharmacognostical (1) | pharmacognosy study (1) |
| Pharmacokinetic (4) | Pharmacokinetic interactions. (1) | pharmacokinetics (8) |
| Pharmacokinetics. (2) | Pharmacological properties (1) | Pharmacophore (3) |
| Pharmacovigilance (14) | Pharmacovigilance Programme of India (1) | Pharmacovigilance. (1) |
| Pharmacovigilante’s (1) | pharmacy (5) | pharmacy curriculum (2) |
| Pharmacy education (1) | Pharmacy Enforcement Division (1) | Pharmacy informatics (1) |
| Pharmacy intervention (1) | Pharmacy services (1) | Pharmacy students (1) |
| Phase diagrams (1) | Phase I studies (1) | Phase rule (1) |
| phase solubility (1) | phase solubility profile (1) | Phenobarbitone (1) |
| Phenolic (1) | phenolic compounds (2) | phenolics (1) |
| phenols (1) | Phenothiazine (1) | Phenytoin (2) |
| Phenytoin cold cream (1) | Phenytoin Toxicity (1) | Pheritima posthuma (1) |
| Phleboliths (1) | Phoenix dactylifera (1) | Phosphorylase kinase (1) |
| Photoprotection. (2) | Phthalates (1) | Phyllanthus emblica, (1) |
| Phylogenetic tree (1) | Physical fitness (1) | Physical stability (1) |
| Physichochemical Characterization (1) | Physicians (3) | physicochemical evaluation (1) |
| physicochemical properties (1) | physiochemical descriptor (1) | Physiological role (1) |
| Phytochemical (2) | phytochemical prospection (1) | Phytochemical screening (1) |
| Phytosome (1) | picrotoxin (1) | pictograms (1) |
| Pilgrims (1) | PIM (1) | Pinus merkusii (1) |
| pioglitazone (1) | piperazine citrate (1) | Piperine (2) |
| Piroxicam (2) | Pits and Fissures (1) | Pixel intensity. (1) |
| Plackett-Burman (1) | Plackett-Burman design (1) | plant extracts (1) |
| plasma (3) | Plasma concentration (1) | plasma concentrations (1) |
| Plasma creatinine (1) | Plasma insulin (1) | Plasma urea (1) |
| plasma-brain correlation (1) | Plasma. (1) | Plasmodium falciparum 3D7 (1) |
| Plasmodium falciparum. (1) | Platelet aggregation. (1) | Platelet rich fibrin membrane. (1) |
| Pleiotropic effects (1) | PLGA (1) | PLSR (1) |
| Pluronic F 127 (1) | PM6 (1) | PM7 (1) |
| Pneumonia (1) | Poison (2) | Poisoning pattern (1) |
| Polarography (1) | Poloxamer 188 (1) | Poloxamer 407 (2) |
| Poloxamer 407. (1) | poly (lactic-co-glycolic acid) (1) | Poly herbal (1) |
| poly(ε-caprolactone) (1) | polycaprolactone (1) | Polycystic Ovary Syndrome (1) |
| Polyelectrolyte complex (PEC) (1) | PolyElectrolytecomplex (1) | Polyethylene glycol (1) |
| Polyherbal (1) | polyherbal formulation (3) | Polymeric nanoparticles (2) |
| polypharmacy (6) | polypharmacy in diabetes mellitus. (1) | polyphenols (1) |
| Polysaccharide (1) | polyvinyl alcohol (2) | polyvinyl pyrrolidone (1) |
| Polyvinylpyrrolidone (1) | Polyvynil pyrrolidone (1) | Pomalidomide (1) |
| PON1 mRNA (2) | porosity (1) | Port-A Catheter. (1) |
| Positive and Negative stressors (1) | Positive coping strategies. (1) | Posology (1) |
| Possible mechanisms (1) | Posterior reversible encephalopathy syndrome (1) | Potassium (1) |
| Potassium Channel (1) | Potassium chloride (1) | Potassium Nitrate (1) |
| PPAR agonists (1) | PPARγ agonists. (1) | PPBG (1) |
| pPharmacokinetics (1) | PPP model (1) | practice (3) |
| practices (1) | pravastatin (1) | Pre ADMET (1) |
| pre prandial (1) | Pre University students (1) | Pre-authorization (1) |
| Prebiotic (2) | Precipitation (1) | precise (1) |
| Precision (1) | Predictors (1) | Pregabalin (1) |
| Pregnancy (3) | preliminary screening (1) | Premna esculenta (1) |
| prescriber (1) | Prescribing (1) | Prescribing errors (1) |
| Prescribing pattern. (1) | Prescription (3) | Prescription error. (1) |
| prescription monitoring (1) | prescription only medicines (1) | Prescription pattern (1) |
| Prescription review (1) | pressure dependent approach (1) | Prevalence (3) |
| Primary health care (2) | Primary Health Care. (1) | Principal component analysis (1) |
| principal component regression (1) | Pristane (1) | Private Medical College (1) |
| PRO (1) | Probable (1) | Probiotic (1) |
| Probiotics (1) | Problem-based learning (1) | process capability (1) |
| Process parameters. (1) | Products with Antimicrobial Action. (1) | progesterone (1) |
| Proniosomal gel (1) | propolis (1) | Proportional reporting ratio (1) |
| propranol hydrochloride (1) | Propranolol hydrochloride (1) | Prospective Study (2) |
| prostaglandins (1) | Proteasome activity (1) | protein proÞ le (1) |
| proteolytic enzymes (1) | Proton adduct (1) | Proton Pump Inhibitor (2) |
| Proton-pump Inhibitors (1) | Protransfersome (1) | Prteomics (1) |
| Pseudo ternary phase diagrams (1) | Pseudomonas aeruginosa (1) | Psidium Guajava (1) |
| Psychological mindedness (1) | Psychomotor (1) | Psychosis (2) |
| Psychotropic drugs (1) | Psychotropics (1) | Pterocarpus indicus (1) |
| Pterocarpus indicus Willd (1) | Public behavior (1) | Public health hospital (1) |
| Public hospital (1) | Publication (1) | Publications (2) |
| Pulmonary Fibrosis (1) | pulmonary hypertension (1) | Pulmonary toxicity (1) |
| Punica granatum (1) | pyrazine (1) | pyrazoline (1) |
| pyrazolines (1) | Pyrimidine (1) | Q1F (1) |
| QOL (1) | QSAR (2) | qualitative (1) |
| Qualitative analysis (1) | qualitative study (1) | Quality (1) |
| quality assurance (1) | Quality Control (1) | Quality Indicators (1) |
| quality of internet information (1) | quality of life (4) | quantitative structure-activity relationship (1) |
| Quercetin (2) | quinazolin-4(3H)one (1) | quinazolinone (1) |
| Quinazolinone. (1) | quinoline derivatives (1) | R2 values (1) |
| Rabbits. (1) | radical scavenger (1) | radicals (1) |
| radiopharmaceuticals (1) | radiopharmacy (1) | Radioprotective (1) |
| Raillietina echinobothrida (1) | raloxifene hydrochloride (1) | Raman spectroscopy (2) |
| ramipril (2) | ranitidine (1) | Ranitidine hydrochloride (2) |
| Ranitidine’. (1) | ranolazine (1) | Ransmission electron microscopy (1) |
| Rapid disintegration (1) | Rasagiline mesylate (1) | Rat (1) |
| ratio test procedures (1) | Rational pharmacotherapy. (1) | Rational prescribing (1) |
| Rational use of medicine (1) | rational use of medicines (1) | rats (1) |
| Rattus novergicus (1) | re-precipitation (1) | recognized standards (1) |
| recovery studies (1) | Red ginger (1) | Reflective pedagogy paradigm (1) |
| reforms (1) | Regeneration (1) | Regression analysis (1) |
| Regressions statistics (1) | Regulation (1) | Regulations (1) |
| regulatory (2) | Regulatory affairs (1) | regulatory system (1) |
| Relative performance (1) | release kinetics (3) | Release studies. (1) |
| relese kinetics (1) | Removable denture (1) | Renoprotection (1) |
| Renoprotective (1) | repaglinide (2) | reperfusion (1) |
| research (1) | Research Skills. (1) | reserpine (1) |
| Resident doctors (1) | Resistance (3) | Resistant starch (1) |
| Resource poor setting (1) | Respiratory tract (1) | Response Surface Methodology (1) |
| Response surface methodology. (1) | Response to antiretroviral therapy (1) | Resveratrol (2) |
| retail pharmacy (1) | Retention. (1) | Retinopathy (1) |
| retrospective cohort (1) | Retrospective study (2) | reversed-phase chromatography (1) |
| Rhabdomyolysis (1) | Rhaphidophora pinnata (1) | rhizomes (1) |
| Riboflavin (1) | Rice Bran Oil (1) | Rifampicin (1) |
| Ringer’s dextrose (1) | Ringer’s lactate. (1) | Riociguat (1) |
| Risk factor. (1) | Risk factors (2) | Risk Factors. (1) |
| Rituximab (1) | rivastigmine (1) | RNAi (1) |
| RNAi technology (1) | RNTCP (1) | Rodenticides (1) |
| root (1) | Root canal infection (1) | Roots extract (1) |
| Ropinirole (1) | rosuvastatin (2) | rosuvastatin calcium (1) |
| Royal Malaysian Custom Officer (1) | RP-HPLC (6) | RP-HPLC method (1) |
| RP-TLC/Densitometry (1) | RT-qPCR (1) | Rubus fraxinifolius (1) |
| Rubus rosifolius (1) | rupatadine (1) | rutin (1) |
| ß avonoids (2) | S. mutans (1) | S.salivarius (1) |
| S.sanguis (1) | Saccharin (1) | Safe handling guidelines (1) |
| Safety (1) | Sage (1) | Saponin (1) |
| saponins (1) | Sappan wood (1) | Saraschandra (1) |
| Saudi Arabia (1) | Saussurea lappa (1) | scanning electron microscopy (3) |
| Scientific Advertisements (1) | Scientometrics (3) | sclerotherapy (1) |
| Scores. (1) | Se- DeM ODT Expert system (1) | Second-line agents (1) |
| Secondary Level (1) | seizure outcome (1) | Seizures (1) |
| Selected area electron diffraction (1) | Self medication (1) | self-emulsifying drug delivery system (1) |
| Self-Harm (1) | self-medication (5) | self-nanoemulsification (1) |
| Semi-permanent hair dye (1) | senna spectabilis (1) | Sensitive (1) |
| sensory cortical activity. (1) | separation (1) | sepbox (1) |
| Septic shock (1) | Sequences distillation (1) | Sequential optimization (1) |
| Serum (1) | Serum Ferritin (1) | Serum Glutamate-Pyruvate Transaminase (1) |
| Serum Glutamic Oxaloacetic Transaminase (1) | Serum triglyceride (1) | Serum Vitamin D (1) |
| Serum. (1) | sesame oil (1) | severe febrile neutropenia (1) |
| Severe sepsis (1) | Severity (1) | Sexual dysfunction in diabetes (1) |
| Shodhana (1) | Short Communication (3) | short-term memory (1) |
| Sida rhomboidea.Roxb (1) | Side effect (1) | signal detection (1) |
| Signal detection. (1) | Silver nanoparticles (1) | silymarin (1) |
| similarity factor (f2) (2) | simplex lattice (1) | Simplex Lattice Design (2) |
| simultaneous determination (2) | simultaneous extraction (1) | simvastatin (1) |
| simvastatin. (1) | Single nucleotide polymorphism (1) | sintering (1) |
| siRNA (1) | siRNA. (2) | SIRT1 (1) |
| Sirtuin (1) | six sigma (1) | SJS (1) |
| SLAM markers (1) | SLS (1) | Smix. (1) |
| Smoking (1) | smoking cessation. (1) | Smoking. (1) |
| smooth muscle cells (1) | Snake bite (1) | SNEDDS (2) |
| sobatum (1) | Social Media (1) | Social sexual. (1) |
| SOD (1) | Sodium (1) | sodium alginate (1) |
| sodium alginate. (2) | sodium carboxy methyl cellulose (1) | sodium starch glycolate (3) |
| Sodium starch glycolate (SSG) (1) | Solanum nigrum (1) | Solanum trilobatum (1) |
| Solanum viarum (1) | Solanum xanthocarpum, (1) | Solasodine (1) |
| solid dispersion (5) | solid lipid nanoparticles (1) | Solid lipid nanoparticles. (1) |
| Solid Phase Extraction (1) | solubility (5) | Solubility enhancement (1) |
| Solubility. (1) | solvent casting (1) | solvent evaporation (3) |
| Solvent evaporation. (1) | sonication time (1) | sonophoresis (1) |
| Sorafenib (1) | Spacedrepetition. (1) | spasmolytic (1) |
| speciÞ city (1) | Spectrometric (1) | spectrophotometry (2) |
| sperm count (2) | SPF (1) | Spiro compounds (1) |
| Spleen colony assay (1) | sponge implantation assay (1) | sponsors (1) |
| Spontaneous-Reporting. (1) | Sprague Dawley (1) | spray drying (1) |
| SPSS 20. (1) | ST segment elevation (1) | stability (1) |
| stability indicating (1) | stability indicating and validation. (1) | Stability indicating assay (1) |
| Stability indicating assay method (1) | stability indicating method of artemether (1) | stability indicating. (1) |
| Stability of the physical properties (1) | Stability test (1) | stability. (1) |
| stain removal (1) | stakeholders (1) | Standardization (4) |
| Staphylococcus aureus (1) | Starlac (1) | Statin pathway (1) |
| Statins. (1) | Statistical Modeling (1) | Statistical optimization (1) |
| Stelechocarpus burahol (1) | Stem bark extract (1) | Stephania hernandifolia (1) |
| Stereospermum suaveolens (1) | Stereospermum tetragonum (2) | Sterilization Procedures (1) |
| Steroidal alkaloid (1) | Steudnera colocasiifolia (1) | Stevens-Johnson syndrome (1) |
| Stilbene (1) | Stimulantia (1) | Stimuli (1) |
| Stomatitis under prosthesis (1) | Streptococci (1) | Streptococcus mutans (2) |
| Streptokinase (1) | Streptomonospora arabica (1) | Streptomyces (1) |
| Streptozotocin (2) | Streptozotocin (STZ) (1) | streptozotocin-induced diabetes (1) |
| Streptozotocin. (1) | stress (3) | stress studies (2) |
| stroke and cardiac pacemaker. (1) | Stroke prevention (1) | structural descriptor (1) |
| Structured Communication. (1) | Stryphnodendron rotundifolium (1) | students (3) |
| students’ residence (1) | Sub Clinical Hypothyroidism. (1) | Sub-acute Inflammation (1) |
| Subcutaneous fat (1) | sublingual films (1) | substituted acetophenones (1) |
| sucrase (1) | Sudan (1) | Sulfonylurea (2) |
| Sulfonylureas (1) | Sulphorhodamine-B (1) | Sun (1) |
| sun protection factor (2) | Sunlight (1) | Sunscreens. (1) |
| Super disintegrants (1) | superdisintegrants (2) | Superdisintergrants (1) |
| Superoxide Dismutase. (1) | superoxidedismutase (1) | superporous hydrogel composite (1) |
| Supply Chain Management (1) | support staff. (1) | Surface properties (1) |
| surfactant (1) | surfactants (1) | surgical prophylaxis. (1) |
| Surgical. (1) | Survey questionnaire (1) | survey. (1) |
| Survival rate (1) | sustained release (3) | sustained release pellets (1) |
| sustained release. (1) | Sweet orange peel extract (Citrus sinensis) (1) | swelling index (1) |
| swelling studies (1) | Symptoms (1) | Synchronous spectrofluorimetry. (1) |
| Synergism. (1) | Synthesis (2) | Synthesis; 1-allyl-3-benzoylthiourea; COX-2; Analgesic; Lead Compound; (1) |
| Systematic Review. (1) | Systemic steroids. (1) | Systems biotechnology (1) |
| Systolic dysfunction. (1) | T cell epitope (1) | T regs (1) |
| Tab. Pardopa (1) | Tablet Compression (1) | Tacrolimus (1) |
| Tacrolimus Once Daily (1) | Tacrolimus Twice Daily. (1) | Tactile stimulation (1) |
| tail suspension test (1) | Tamarindus indica (1) | Tamilians (1) |
| Tamoxifen (1) | Target delivery (1) | Targeted drug delivery system (1) |
| taste masking (2) | tasteless complex (1) | taxane (1) |
| Taxus baccata (1) | Teaching Hospital (1) | Technology (1) |
| technology-enhanced learning (1) | tegument (1) | telmisartan (1) |
| TEN (1) | Tenofovir disoproxil fumarate (1) | Tephrosia purpurea ethanolic seed extract (TpEt). (1) |
| Terminalia bellirica (1) | Termineliachebula;Plants; Galls;Albendazole; anthelmintic; Drug. (1) | Ternary phase diagram (1) |
| terpenoids (1) | Tertiary Care (1) | Tertiary care hospital (2) |
| testicular damage (1) | testosterone (3) | Tetrapreniltoluquinone (1) |
| thalassemia major (1) | therapeutic angiogenesis (1) | therapeutic dose (1) |
| therapeutic drug monitoring (2) | therapeutic effectiveness (1) | Thermoreversible gel (1) |
| Thixogel (1) | THP-1 (2) | Three component system (1) |
| thrombocytopenia (1) | Thrombolysed subjects (1) | Thrombolytic (1) |
| thrombolytic enzymes (1) | Thyme oleoresin (1) | Thyrotoxicosis. (1) |
| time dependent approach (1) | Time lag (1) | Timed release (1) |
| Tobacco (2) | Tobacco smoking (1) | tolbutamide (1) |
| Tolerance (1) | Tooth brush. (1) | Toothpaste. (1) |
| Topical delivery. (1) | Topical. (1) | Total flavonoid (1) |
| Total flavonoid content (2) | Total phenolic (2) | Total phenolic content (1) |
| total polyphenolic content (1) | total quality management (1) | toxicity (5) |
| Toxicity. (2) | traditional medicine (2) | Training of Central sterile and supply department employees (1) |
| tramadol HCL (1) | Tramadol Hydrochloride (1) | Trans-cinnamic acid (1) |
| Trans-resveratrol (1) | Transcriptomics. (1) | transdermal (2) |
| transfer latency (1) | Transfersome (2) | Transfersomes. (1) |
| Translation (1) | Transmucosal (1) | Transmucosal patch (1) |
| Trauma induced external inflammatory root resorption (1) | Treatment adherence. (1) | Treatment outcomes (1) |
| Treatment success rate (1) | Triacylglycerol. (1) | Triamcinalone Acetonide (TRIA) (1) |
| Trichoderma reesei. (1) | Tricyclic antidepressants (TCA) (1) | Triglycerides (1) |
| Trigonella foenum graecum (1) | Trigonelline (1) | Trinidad & Tobago (1) |
| trinitrobenzene sulfonic acid (1) | Triphala (1) | triple distilled water (1) |
| Triterpenoid. (1) | Triterpenoids (1) | Triticum aestivum. (1) |
| Tropaeolum majus L (1) | tropicamide (1) | Troponin-I (1) |
| Trypsin (1) | TSLP (1) | Tuberculosis (4) |
| Tuberculosis/HIV (1) | Tumor response (1) | Tween 80. (1) |
| Twisted (1) | Tylophora indica (1) | Tylophorinidine. (1) |
| type 2 diabetes (2) | Type 2 diabetes mellitus. (1) | type 2 diabetes. (1) |
| UACR (1) | UCPMP Guidelines (1) | ultrasonication-solvent evaporation technique (1) |
| Ultrasonography (1) | Unani medicine (1) | Uncemented (1) |
| Underutilization of insulin. (1) | Unethical practices. (1) | Unique device identification (1) |
| Universities (1) | Unlicensed. (1) | Unnecessary use. (1) |
| Unused/Unwanted medicines (1) | UPLC/ESI-Q-TOF-MS/MS method Validation (1) | Urban area (1) |
| urea (1) | Urinary Hydrogen Peroxide (1) | Urinary tract infection (UTI) (1) |
| Urine Albumin to Creatinine Ratio (1) | Urine volume (1) | urolithiasis (1) |
| Urtica dioica L (1) | Usefulness. (1) | Uterine fibroid (1) |
| Uterine Perforation. (1) | UV derivative spectrophotometry (1) | UV detection (2) |
| UV Spectrophotometric method (1) | UV spectrophotometry (1) | UV-spectrophotometric method (1) |
| UV-spectrophotometry (2) | UV-Vis spectroscopy (1) | Vaccine (1) |
| Vaccine design (1) | vada (1) | vaginal gel (1) |
| Vaginitis. (1) | Vakrasana (1) | validation (16) |
| Valium (1) | Valproate (1) | valsartan (1) |
| Vanillin (1) | Vanillosmopsis arborea. (1) | vascular bundle (1) |
| vascular permeability (2) | vascular progenitors (1) | VED analysis (2) |
| VED analysis. (2) | VEGFR-2 (1) | Venetoclax (1) |
| Venography and Hemangioma (1) | Venous malformations (VMs) (1) | verapamil (3) |
| Verapamil HCl (1) | Viability (1) | Vincristine. (1) |
| Vinegar (1) | Virtual Screening (1) | Viscosity (1) |
| visible Spectrophotometry (1) | visible spectroscopy (1) | Visual analogue scale. (1) |
| Vitamin D (3) | Vitamin D deficiency (1) | Vitamin D. (1) |
| vitamin E (1) | vitamin E d-α-tocopheryl polyethylene glyco1000 succinate (1) | Vitamin. (1) |
| Vitex agnus Castus (1) | Voltage–gated calcium channels (1) | warfarin (2) |
| Warning signs (1) | Water hyacinth (2) | web-based learning (1) |
| Weibull parameters (1) | West timor (1) | Western blot technique (1) |
| Wet gangrene (1) | wet granulation (1) | wetting time (1) |
| Wheat (1) | White/red patch (1) | WHO-QOL BREF questionnaire (1) |
| WHO-UMC causality assessment system. (1) | Wilson disease (1) | Wistar rats. (1) |
| Withania somnifera. (1) | Withdrawal (1) | Women. (1) |
| Work protection (1) | Wound Healing (1) | Wound tissue healing (1) |
| Wrightia tinctoria (1) | writhing (1) | X-ray diffraction (1) |
| X-ray imaging study. (1) | X-ray powder diffraction (1) | xanthan gum (1) |
| Xanthangum (1) | XDR-TB (1) | Xenografts (1) |
| Xenografts. (1) | XRD (1) | Ylang-ylang (1) |
| Yoga (1) | Yucca gloriosa L. (1) | Zea m1 pollen allergen (1) |
| Zero order release (1) | zero order spectrophotometry (1) | zeta potential (1) |
| zidovudine (1) | Zika virus (1) | zinc (1) |
| Zinc ion (1) | Zingiber officinale (1) | Zingiberaceae (1) |
| zopiclone (1) | [BMIM]PF6 (1) | Þ rst-order derivative spectroscopy (1) |
| Α-amylase (2) | α-glucosidase (1) | α-mangostin (1) |
| β Amyloid1-42 (1) | β-carboline (1) | β-carotene production (1) |
| β-cyclodextrin (3) | γ-oryzanol (1) | ε-amino groups (1) |
